Trial Profile

Planned phase III trial of recombinant factor VIIa in the treatment of congenital haemophilia A or B in paediatric patients with inhibitors to factor VIII or IX.

Status: Recruiting

Phase of Trial: Phase III

Latest Information Update: 26 Jul 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

01 Jul 2022 Results assessing efficacy and safety for treatment of bleeding in children <12 years of age with haemophilia A or B with inhibitorspublished in the Haemophilia
24 Mar 2015 An independent Data Monitoring Committee has concluded that interim data from the PERSEPT 1 trial support the initiation of this trial, according to an LFB media release.
24 Mar 2015 Planned initiation date changed from 1 Mar 2015 to 1 Dec 2015, as reported in an LFB media release.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com